Former UFC heavyweight champion has been notified by the US Anti-Doping Agency of a failed out-of-competition drug research on 28 June
Brock Lesnar has been pennant for a potential anti-doping violation in the wake of his unanimous-decision succes over Mark Hunt at UFC 200.
The UFC problem the following statement on Friday afternoon saying Lesnar and the publicity had been notified by the US Anti-Doping Agency of a failed out-of-competition pharmaceutical measure on 28 June. Usada did not discloses the appoint of the substance Lesnar tested positive for in keeping with organizational policy.
A decorated amateur wrestler, Lesnar signed with the UFC in 2007 and defeated Randy Couture for the advertisings heavyweight championship the following financial year. He induced two successful entitlement defenses before losing to Cain Velasquez by first-round TKO, then announced his retirement from mixed martial arts after a strike loss to Alistair Overeem in 2011.
Saturdays fight with Hunt was Lesnars first in five years old. The 38 -year-old South Dakota native earned a record $2.5 m handbag for the three-round moments win, with all three judges siding down scores of 29 -2 8.
The UFC said Usada, the independent head of the organizations anti-doping programme, received the testing the outcomes of the 28 June sample collect on Thursday evening after it was measured at the Wada-accredited UCLA Olympic Analytical Laboratory.
The original headline bout of Saturdays card a light-headed heavyweight entitle combat between Jon Jones and Daniel Cormier was scrapped when Jones are positive for a censored element. Cormier instead opposed Anderson Silva on the undercard, while the womens bantamweight championship engage between Amanda Nunes and Miesha Tate was hoisted to the main event.
The UFC 200 main event had to be scrapped three days before the happen because Jon Jones tested positive for banned substances in an out-of-competition test. Daniel Cormier campaigned Anderson Silva instead. Jones is also awaiting the USADA adjudication process.
Read more: www.theguardian.com